acetaminophen · Taro · NDA 018337, 204767, 204957, 206610, 206968
Acetaminophen
Earliest generic entry, as listed · earliest of 5 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8741959 | drug product | 19 Apr 2030 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 8
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 018337 · 001 · RLD · discontinued | suppository, rectal | 650MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | open |
| 018337 · 002 · RLD | suppository, rectal | 325MG | open |
| 018337 · 003 · RLD | suppository, rectal | 120MG | open |
| 204767 · 001 | solution, intravenous | 1GM/100ML (10MG/ML) | 19 Apr 2030 |
| 204957 · 001 · RLD | solution, intravenous | 500MG/50ML (10MG/ML) | open |
| 204957 · 002 · RLD | solution, intravenous | 1GM/100ML (10MG/ML) | open |
| 206610 · 001 · RLD · discontinued | powder, intravenous | 1GM/VIAL | open |
| 206968 · 001 · RLD | solution, intravenous | 1GM/100ML (10MG/ML) | open |